(Q36473293)

14 August 2017

1 reference

title

Atopic eczema: what's new? (English)

1 reference

14 August 2017

4

Ring J

1 reference

14 August 2017

Möhrenschlager M

1

1 reference

14 August 2017

Darsow U

series ordinal

2

1 reference

14 August 2017

Schnopp C

series ordinal

3

1 reference

14 August 2017

publication date

1 May 2006

1 reference

Journal of the European Academy of Dermatology and Venereology

14 August 2017

published in

1 reference

14 August 2017

volume

20

1 reference

14 August 2017

issue

5

1 reference

14 August 2017

page(s)

503-11, 513; quiz 512

1 reference

How atopic is atopic dermatitis?

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

Why are allergies increasing?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

Atopic dermatitis: summary of the 1st Georg Rajka Symposium 1998 and a literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

Respiratory symptoms and atopy in children in Aberdeen: questionnaire studies of a defined school population repeated over 35 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

Genetic linkage of childhood atopic dermatitis to psoriasis susceptibility loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

The genetics of atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

New concepts in the pathogenesis of atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

A major susceptibility locus for atopic dermatitis maps to chromosome 3q21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

Linkage and association studies of STAT6 gene polymorphisms and allergic diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

Association of a STAT 6 haplotype with elevated serum IgE levels in a population based cohort of white adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

Airborne and dietary allergens in atopic eczema: a comprehensive review of diagnostic tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

Atopy patch test with different vehicles and allergen concentrations: an approach to standardization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

The prevalence of positive reactions in the atopy patch test with aeroallergens and food allergens in subjects with atopic eczema: a European multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

Childhood risk factors for atopy and the importance of early intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

Prevention of allergic disease in childhood: clinical and epidemiological aspects of primary and secondary allergy prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

Effect of mattress encasings on atopic dermatitis outcome measures in a double-blind, placebo-controlled study: the Dutch mite avoidance study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

Double-blind placebo-controlled house dust mite control measures in adult patients with atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

Breastfeeding duration is a risk factor for atopic eczema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

Effect of exclusive breast-feeding and early solid food avoidance on the incidence of atopic dermatitis in high-risk infants at 1 year of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

Breast-feeding and the onset of atopic dermatitis in childhood: a systematic review and meta-analysis of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

Promotion of Breastfeeding Intervention Trial (PROBIT): a randomized trial in the Republic of Belarus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

Exclusive breastfeeding and risk of atopic dermatitis in some 8300 infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

Allergy development and the intestinal microflora during the first year of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

Effects of probiotics on atopic dermatitis: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

Critical evaluation of food and mite allergy in the management of atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

Diet and asthma, allergic rhinoconjunctivitis and atopic eczema symptom prevalence: an ecological analysis of the International Study of Asthma and Allergies in Childhood (ISAAC) data. ISAAC Phase One Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

Role of Foods in Irregular Aggravation of Atopic Dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

The introduction of solids in relation to asthma and eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

Topical tacrolimus (FK506) leads to profound phenotypic and functional alterations of epidermal antigen-presenting dendritic cells in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

Human epidermal Langerhans' cells are targets for the immunosuppressive macrolide tacrolimus (FK506).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

The ascomycin macrolactam pimecrolimus (Elidel, SDZ ASM 981) is a potent inhibitor of mediator release from human dermal mast cells and peripheral blood basophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

Systemic exposure, tolerability, and efficacy of pimecrolimus cream 1% in atopic dermatitis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

Topical tacrolimus (FK506) and mometasone furoate in treatment of dyshidrotic palmar eczema: a randomized, observer-blinded trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

Tacrolimus ointment 0.03% is safe and effective for the treatment of mild to moderate atopic dermatitis in pediatric patients: results from a randomized, double-blind, vehicle-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

Advances in allergic skin diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

Cost-effectiveness analysis of tacrolimus ointment versus high-potency topical corticosteroids in adults with moderate to severe atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

Clinical practice. Atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

Summary of clinical trials with zafirlukast

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

The leukotriene D4-receptor antagonist, ICI 204,219, relieves symptoms of acute seasonal allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

The leukotriene antagonist montelukast as a therapeutic agent for atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

Montelukast in the treatment of children with moderate-to-severe atopic dermatitis: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

Leukotriene receptor antagonists are ineffective for severe atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

Brief case series: montelukast, at doses recommended for asthma treatment, reduces disease severity and increases soluble CD14 in children with atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

Atopic dermatitis: the skin as a window into the pathogenesis of chronic allergic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

Evidence for the involvement of bacterial superantigens in psoriasis, atopic dermatitis, and Kawasaki syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

Silver. I: Its antibacterial properties and mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

A controlled trial of traditional Chinese herbal medicine in Chinese patients with recalcitrant atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

Atopic dermatitis symptoms decreased in children following massage therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

Atopic dermatitis is associated with a low-producer transforming growth factor β1 cytokine genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

Effectiveness of occlusive bedding in the treatment of atopic dermatitis - a placebo-controlled trial of 12 months' duration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

Evaluation of the staphylococcal exotoxins and their specific IgE in childhood atopic dermatitis☆☆☆

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

Dichotomic nature of atopic dermatitis reflected by combined analysis of monocyte immunophenotyping and single nucleotide polymorphisms of the interleukin-4/interleukin-13 receptor gene: the dichotomy of extrinsic and intrinsic atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

Development of atopic dermatitis-like skin lesions in STAT6-deficient NC/Nga mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

Exposure to pets and atopy-related diseases in the first 4 years of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

Double-blind controlled trial of effect of housedust-mite allergen avoidance on atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

Effect of house dust mite avoidance measures in children with atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

Risk factors for atopic dermatitis in New Zealand children at 3.5 years of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

Differences in fecal microflora between patients with atopic dermatitis and healthy control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

Effect of probiotic Lactobacillus strains in children with atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

Guidelines of care for atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. Pediatric Montelukast Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

Leukotrienes in skin of atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

The leukotriene antagonist zafirlukast as a therapeutic agent for atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

Evidence for a disease-promoting effect of Staphylococcus aureus-derived exotoxins in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

Effect of gentian violet, corticosteroid and tar preparations in Staphylococcus-aureus-colonized atopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

Silver-coated textiles reduce Staphylococcus aureus colonization in patients with atopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

Analysis of Chinese herbal creams prescribed for dermatological conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

Treatment of eczema by EMG biofeedback and relaxation training: a multiple baseline analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

[Education programs on atopic eczema. Design and first results of the German Randomized Intervention Multicenter Study]

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01580.X

10.1111/J.1468-3083.2006.01580.X

21 January 2018

Identifiers

DOI

1 reference

14 August 2017

1 reference